img

Global NGS-Based Monitoring and Diagnostic Test Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Latest Trends

Publisher : MRA | Format : PDF

Global NGS-Based Monitoring and Diagnostic Test Market Insights, Forecast to 2034

NGS-Based Monitoring and Diagnostic Test is based on the NGS, aiming for the monitoring and diagnostic test. Next generation sequencing (NGS), massively parallel or deep sequencing are related terms that describe a DNA sequencing technology which has revolutionised genomic research. Using NGS an entire human genome can be sequenced within a single day.
Market Analysis and InsightsGlobal NGS-Based Monitoring and Diagnostic Test Market
The global NGS-Based Monitoring and Diagnostic Test market is projected to grow from US$ million in 2023 to US$ million by 2033, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for NGS-Based Monitoring and Diagnostic Test is estimated to increase from $ million in 2023 to reach $ million by 2033, at a CAGR of % during the forecast period of 2023 through 2033.
The China market for NGS-Based Monitoring and Diagnostic Test is estimated to increase from $ million in 2023 to reach $ million by 2033, at a CAGR of % during the forecast period of 2023 through 2033.
The Europe market for NGS-Based Monitoring and Diagnostic Test is estimated to increase from $ million in 2023 to reach $ million by 2033, at a CAGR of % during the forecast period of 2023 through 2033.
The global key companies of NGS-Based Monitoring and Diagnostic Test include Agilent Technologies, Inc., Ancestry.com LLC, ArcherDX, Inc., Beijing Genomics Institute (BGI), Cancer Genetics, Inc., CENTOGENE AG, F. Hoffmann-La Roche Ltd, GenePath Dx and Illumina, Inc., etc. in 2023, the global top five players had a share approximately % in terms of revenue.
Report Includes
This report presents an overview of global market for NGS-Based Monitoring and Diagnostic Test market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2023, estimates for 2023, and projections of CAGR through 2033.
This report researches the key producers of NGS-Based Monitoring and Diagnostic Test, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for NGS-Based Monitoring and Diagnostic Test, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the NGS-Based Monitoring and Diagnostic Test revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global NGS-Based Monitoring and Diagnostic Test market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2033. Evaluation and forecast the market size for NGS-Based Monitoring and Diagnostic Test revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Agilent Technologies, Inc., Ancestry.com LLC, ArcherDX, Inc., Beijing Genomics Institute (BGI), Cancer Genetics, Inc., CENTOGENE AG, F. Hoffmann-La Roche Ltd, GenePath Dx and Illumina, Inc., etc.



By Company


Agilent Technologies, Inc.
Ancestry.com LLC
ArcherDX, Inc.
Beijing Genomics Institute (BGI)
Cancer Genetics, Inc.
CENTOGENE AG
F. Hoffmann-La Roche Ltd
GenePath Dx
Illumina, Inc.
Laboratory Corporation of America Holdings
Myriad Genetics, Inc.
QIAGEN N.V.
Quest Diagnostics Incorporated
Siemens Healthineers, Inc.
Thermo Fisher Scientific Inc.
HTG Molecular Diagnostics, Inc.
Vela Diagnostics Pte. Ltd.
Segment by Type
Commercial Assays/Tests
Laboratory Developed Tests
Direct to Consumer Test
Pre-Commercial Tests

Segment by Application


Out-Patient Clinics/General Practitioners
Diagnostic Centers
Hospitals
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East, Africa, and Latin America
Turkey
Saudi Arabia
UAE
Rest of MEA

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Revenue of NGS-Based Monitoring and Diagnostic Test in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3Detailed analysis of NGS-Based Monitoring and Diagnostic Test companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by type, by application and by country, revenue for each segment.
Chapter 7Europe by type, by application and by country, revenue for each segment.
Chapter 8China by type and by application revenue for each segment.
Chapter 9Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, NGS-Based Monitoring and Diagnostic Test revenue, gross margin, and recent development, etc.
Chapter 12Analyst's Viewpoints/Conclusions

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global NGS-Based Monitoring and Diagnostic Test Market Size Growth Rate by Type, 2018 VS 2023 VS 2033
1.2.2 Commercial Assays/Tests
1.2.3 Laboratory Developed Tests
1.2.4 Direct to Consumer Test
1.2.5 Pre-Commercial Tests
1.3 Market by Application
1.3.1 Global NGS-Based Monitoring and Diagnostic Test Market Size Growth Rate by Application, 2018 VS 2023 VS 2033
1.3.2 Out-Patient Clinics/General Practitioners
1.3.3 Diagnostic Centers
1.3.4 Hospitals
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global NGS-Based Monitoring and Diagnostic Test Market Perspective (2018-2033)
2.2 Global NGS-Based Monitoring and Diagnostic Test Growth Trends by Region
2.2.1 NGS-Based Monitoring and Diagnostic Test Market Size by Region: 2018 VS 2023 VS 2033
2.2.2 NGS-Based Monitoring and Diagnostic Test Historic Market Size by Region (2018-2023)
2.2.3 NGS-Based Monitoring and Diagnostic Test Forecasted Market Size by Region (2024-2033)
2.3 NGS-Based Monitoring and Diagnostic Test Market Dynamics
2.3.1 NGS-Based Monitoring and Diagnostic Test Industry Trends
2.3.2 NGS-Based Monitoring and Diagnostic Test Market Drivers
2.3.3 NGS-Based Monitoring and Diagnostic Test Market Challenges
2.3.4 NGS-Based Monitoring and Diagnostic Test Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue NGS-Based Monitoring and Diagnostic Test by Players
3.1.1 Global NGS-Based Monitoring and Diagnostic Test Revenue by Players (2018-2023)
3.1.2 Global NGS-Based Monitoring and Diagnostic Test Revenue Market Share by Players (2018-2023)
3.2 Global NGS-Based Monitoring and Diagnostic Test Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of NGS-Based Monitoring and Diagnostic Test, Ranking by Revenue, 2021 VS 2023 VS 2023
3.4 Global NGS-Based Monitoring and Diagnostic Test Market Concentration Ratio
3.4.1 Global NGS-Based Monitoring and Diagnostic Test Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by NGS-Based Monitoring and Diagnostic Test Revenue in 2023
3.5 Global Key Players of NGS-Based Monitoring and Diagnostic Test Head office and Area Served
3.6 Global Key Players of NGS-Based Monitoring and Diagnostic Test, Product and Application
3.7 Global Key Players of NGS-Based Monitoring and Diagnostic Test, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 NGS-Based Monitoring and Diagnostic Test Breakdown Data by Type
4.1 Global NGS-Based Monitoring and Diagnostic Test Historic Market Size by Type (2018-2023)
4.2 Global NGS-Based Monitoring and Diagnostic Test Forecasted Market Size by Type (2024-2033)
5 NGS-Based Monitoring and Diagnostic Test Breakdown Data by Application
5.1 Global NGS-Based Monitoring and Diagnostic Test Historic Market Size by Application (2018-2023)
5.2 Global NGS-Based Monitoring and Diagnostic Test Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America NGS-Based Monitoring and Diagnostic Test Market Size (2018-2033)
6.2 North America NGS-Based Monitoring and Diagnostic Test Market Size by Type
6.2.1 North America NGS-Based Monitoring and Diagnostic Test Market Size by Type (2018-2023)
6.2.2 North America NGS-Based Monitoring and Diagnostic Test Market Size by Type (2024-2033)
6.2.3 North America NGS-Based Monitoring and Diagnostic Test Market Share by Type (2018-2033)
6.3 North America NGS-Based Monitoring and Diagnostic Test Market Size by Application
6.3.1 North America NGS-Based Monitoring and Diagnostic Test Market Size by Application (2018-2023)
6.3.2 North America NGS-Based Monitoring and Diagnostic Test Market Size by Application (2024-2033)
6.3.3 North America NGS-Based Monitoring and Diagnostic Test Market Share by Application (2018-2033)
6.4 North America NGS-Based Monitoring and Diagnostic Test Market Size by Country
6.4.1 North America NGS-Based Monitoring and Diagnostic Test Market Size by Country: 2018 VS 2023 VS 2033
6.4.2 North America NGS-Based Monitoring and Diagnostic Test Market Size by Country (2018-2023)
6.4.3 North America NGS-Based Monitoring and Diagnostic Test Market Size by Country (2024-2033)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe NGS-Based Monitoring and Diagnostic Test Market Size (2018-2033)
7.2 Europe NGS-Based Monitoring and Diagnostic Test Market Size by Type
7.2.1 Europe NGS-Based Monitoring and Diagnostic Test Market Size by Type (2018-2023)
7.2.2 Europe NGS-Based Monitoring and Diagnostic Test Market Size by Type (2024-2033)
7.2.3 Europe NGS-Based Monitoring and Diagnostic Test Market Share by Type (2018-2033)
7.3 Europe NGS-Based Monitoring and Diagnostic Test Market Size by Application
7.3.1 Europe NGS-Based Monitoring and Diagnostic Test Market Size by Application (2018-2023)
7.3.2 Europe NGS-Based Monitoring and Diagnostic Test Market Size by Application (2024-2033)
7.3.3 Europe NGS-Based Monitoring and Diagnostic Test Market Share by Application (2018-2033)
7.4 Europe NGS-Based Monitoring and Diagnostic Test Market Size by Country
7.4.1 Europe NGS-Based Monitoring and Diagnostic Test Market Size by Country: 2018 VS 2023 VS 2033
7.4.2 Europe NGS-Based Monitoring and Diagnostic Test Market Size by Country (2018-2023)
7.4.3 Europe NGS-Based Monitoring and Diagnostic Test Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China NGS-Based Monitoring and Diagnostic Test Market Size (2018-2033)
8.2 China NGS-Based Monitoring and Diagnostic Test Market Size by Type
8.2.1 China NGS-Based Monitoring and Diagnostic Test Market Size by Type (2018-2023)
8.2.2 China NGS-Based Monitoring and Diagnostic Test Market Size by Type (2024-2033)
8.2.3 China NGS-Based Monitoring and Diagnostic Test Market Share by Type (2018-2033)
8.3 China NGS-Based Monitoring and Diagnostic Test Market Size by Application
8.3.1 China NGS-Based Monitoring and Diagnostic Test Market Size by Application (2018-2023)
8.3.2 China NGS-Based Monitoring and Diagnostic Test Market Size by Application (2024-2033)
8.3.3 China NGS-Based Monitoring and Diagnostic Test Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia NGS-Based Monitoring and Diagnostic Test Market Size (2018-2033)
9.2 Asia NGS-Based Monitoring and Diagnostic Test Market Size by Type
9.2.1 Asia NGS-Based Monitoring and Diagnostic Test Market Size by Type (2018-2023)
9.2.2 Asia NGS-Based Monitoring and Diagnostic Test Market Size by Type (2024-2033)
9.2.3 Asia NGS-Based Monitoring and Diagnostic Test Market Share by Type (2018-2033)
9.3 Asia NGS-Based Monitoring and Diagnostic Test Market Size by Application
9.3.1 Asia NGS-Based Monitoring and Diagnostic Test Market Size by Application (2018-2023)
9.3.2 Asia NGS-Based Monitoring and Diagnostic Test Market Size by Application (2024-2033)
9.3.3 Asia NGS-Based Monitoring and Diagnostic Test Market Share by Application (2018-2033)
9.4 Asia NGS-Based Monitoring and Diagnostic Test Market Size by Region
9.4.1 Asia NGS-Based Monitoring and Diagnostic Test Market Size by Region: 2018 VS 2023 VS 2033
9.4.2 Asia NGS-Based Monitoring and Diagnostic Test Market Size by Region (2018-2023)
9.4.3 Asia NGS-Based Monitoring and Diagnostic Test Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America NGS-Based Monitoring and Diagnostic Test Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America NGS-Based Monitoring and Diagnostic Test Market Size by Type
10.2.1 Middle East, Africa, and Latin America NGS-Based Monitoring and Diagnostic Test Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America NGS-Based Monitoring and Diagnostic Test Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America NGS-Based Monitoring and Diagnostic Test Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America NGS-Based Monitoring and Diagnostic Test Market Size by Application
10.3.1 Middle East, Africa, and Latin America NGS-Based Monitoring and Diagnostic Test Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America NGS-Based Monitoring and Diagnostic Test Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America NGS-Based Monitoring and Diagnostic Test Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America NGS-Based Monitoring and Diagnostic Test Market Size by Country
10.4.1 Middle East, Africa, and Latin America NGS-Based Monitoring and Diagnostic Test Market Size by Country: 2018 VS 2023 VS 2033
10.4.2 Middle East, Africa, and Latin America NGS-Based Monitoring and Diagnostic Test Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America NGS-Based Monitoring and Diagnostic Test Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Agilent Technologies, Inc.
11.1.1 Agilent Technologies, Inc. Company Details
11.1.2 Agilent Technologies, Inc. Business Overview
11.1.3 Agilent Technologies, Inc. NGS-Based Monitoring and Diagnostic Test Introduction
11.1.4 Agilent Technologies, Inc. Revenue in NGS-Based Monitoring and Diagnostic Test Business (2018-2023)
11.1.5 Agilent Technologies, Inc. Recent Developments
11.2 Ancestry.com LLC
11.2.1 Ancestry.com LLC Company Details
11.2.2 Ancestry.com LLC Business Overview
11.2.3 Ancestry.com LLC NGS-Based Monitoring and Diagnostic Test Introduction
11.2.4 Ancestry.com LLC Revenue in NGS-Based Monitoring and Diagnostic Test Business (2018-2023)
11.2.5 Ancestry.com LLC Recent Developments
11.3 ArcherDX, Inc.
11.3.1 ArcherDX, Inc. Company Details
11.3.2 ArcherDX, Inc. Business Overview
11.3.3 ArcherDX, Inc. NGS-Based Monitoring and Diagnostic Test Introduction
11.3.4 ArcherDX, Inc. Revenue in NGS-Based Monitoring and Diagnostic Test Business (2018-2023)
11.3.5 ArcherDX, Inc. Recent Developments
11.4 Beijing Genomics Institute (BGI)
11.4.1 Beijing Genomics Institute (BGI) Company Details
11.4.2 Beijing Genomics Institute (BGI) Business Overview
11.4.3 Beijing Genomics Institute (BGI) NGS-Based Monitoring and Diagnostic Test Introduction
11.4.4 Beijing Genomics Institute (BGI) Revenue in NGS-Based Monitoring and Diagnostic Test Business (2018-2023)
11.4.5 Beijing Genomics Institute (BGI) Recent Developments
11.5 Cancer Genetics, Inc.
11.5.1 Cancer Genetics, Inc. Company Details
11.5.2 Cancer Genetics, Inc. Business Overview
11.5.3 Cancer Genetics, Inc. NGS-Based Monitoring and Diagnostic Test Introduction
11.5.4 Cancer Genetics, Inc. Revenue in NGS-Based Monitoring and Diagnostic Test Business (2018-2023)
11.5.5 Cancer Genetics, Inc. Recent Developments
11.6 CENTOGENE AG
11.6.1 CENTOGENE AG Company Details
11.6.2 CENTOGENE AG Business Overview
11.6.3 CENTOGENE AG NGS-Based Monitoring and Diagnostic Test Introduction
11.6.4 CENTOGENE AG Revenue in NGS-Based Monitoring and Diagnostic Test Business (2018-2023)
11.6.5 CENTOGENE AG Recent Developments
11.7 F. Hoffmann-La Roche Ltd
11.7.1 F. Hoffmann-La Roche Ltd Company Details
11.7.2 F. Hoffmann-La Roche Ltd Business Overview
11.7.3 F. Hoffmann-La Roche Ltd NGS-Based Monitoring and Diagnostic Test Introduction
11.7.4 F. Hoffmann-La Roche Ltd Revenue in NGS-Based Monitoring and Diagnostic Test Business (2018-2023)
11.7.5 F. Hoffmann-La Roche Ltd Recent Developments
11.8 GenePath Dx
11.8.1 GenePath Dx Company Details
11.8.2 GenePath Dx Business Overview
11.8.3 GenePath Dx NGS-Based Monitoring and Diagnostic Test Introduction
11.8.4 GenePath Dx Revenue in NGS-Based Monitoring and Diagnostic Test Business (2018-2023)
11.8.5 GenePath Dx Recent Developments
11.9 Illumina, Inc.
11.9.1 Illumina, Inc. Company Details
11.9.2 Illumina, Inc. Business Overview
11.9.3 Illumina, Inc. NGS-Based Monitoring and Diagnostic Test Introduction
11.9.4 Illumina, Inc. Revenue in NGS-Based Monitoring and Diagnostic Test Business (2018-2023)
11.9.5 Illumina, Inc. Recent Developments
11.10 Laboratory Corporation of America Holdings
11.10.1 Laboratory Corporation of America Holdings Company Details
11.10.2 Laboratory Corporation of America Holdings Business Overview
11.10.3 Laboratory Corporation of America Holdings NGS-Based Monitoring and Diagnostic Test Introduction
11.10.4 Laboratory Corporation of America Holdings Revenue in NGS-Based Monitoring and Diagnostic Test Business (2018-2023)
11.10.5 Laboratory Corporation of America Holdings Recent Developments
11.11 Myriad Genetics, Inc.
11.11.1 Myriad Genetics, Inc. Company Details
11.11.2 Myriad Genetics, Inc. Business Overview
11.11.3 Myriad Genetics, Inc. NGS-Based Monitoring and Diagnostic Test Introduction
11.11.4 Myriad Genetics, Inc. Revenue in NGS-Based Monitoring and Diagnostic Test Business (2018-2023)
11.11.5 Myriad Genetics, Inc. Recent Developments
11.12 QIAGEN N.V.
11.12.1 QIAGEN N.V. Company Details
11.12.2 QIAGEN N.V. Business Overview
11.12.3 QIAGEN N.V. NGS-Based Monitoring and Diagnostic Test Introduction
11.12.4 QIAGEN N.V. Revenue in NGS-Based Monitoring and Diagnostic Test Business (2018-2023)
11.12.5 QIAGEN N.V. Recent Developments
11.13 Quest Diagnostics Incorporated
11.13.1 Quest Diagnostics Incorporated Company Details
11.13.2 Quest Diagnostics Incorporated Business Overview
11.13.3 Quest Diagnostics Incorporated NGS-Based Monitoring and Diagnostic Test Introduction
11.13.4 Quest Diagnostics Incorporated Revenue in NGS-Based Monitoring and Diagnostic Test Business (2018-2023)
11.13.5 Quest Diagnostics Incorporated Recent Developments
11.14 Siemens Healthineers, Inc.
11.14.1 Siemens Healthineers, Inc. Company Details
11.14.2 Siemens Healthineers, Inc. Business Overview
11.14.3 Siemens Healthineers, Inc. NGS-Based Monitoring and Diagnostic Test Introduction
11.14.4 Siemens Healthineers, Inc. Revenue in NGS-Based Monitoring and Diagnostic Test Business (2018-2023)
11.14.5 Siemens Healthineers, Inc. Recent Developments
11.15 Thermo Fisher Scientific Inc.
11.15.1 Thermo Fisher Scientific Inc. Company Details
11.15.2 Thermo Fisher Scientific Inc. Business Overview
11.15.3 Thermo Fisher Scientific Inc. NGS-Based Monitoring and Diagnostic Test Introduction
11.15.4 Thermo Fisher Scientific Inc. Revenue in NGS-Based Monitoring and Diagnostic Test Business (2018-2023)
11.15.5 Thermo Fisher Scientific Inc. Recent Developments
11.16 HTG Molecular Diagnostics, Inc.
11.16.1 HTG Molecular Diagnostics, Inc. Company Details
11.16.2 HTG Molecular Diagnostics, Inc. Business Overview
11.16.3 HTG Molecular Diagnostics, Inc. NGS-Based Monitoring and Diagnostic Test Introduction
11.16.4 HTG Molecular Diagnostics, Inc. Revenue in NGS-Based Monitoring and Diagnostic Test Business (2018-2023)
11.16.5 HTG Molecular Diagnostics, Inc. Recent Developments
11.17 Vela Diagnostics Pte. Ltd.
11.17.1 Vela Diagnostics Pte. Ltd. Company Details
11.17.2 Vela Diagnostics Pte. Ltd. Business Overview
11.17.3 Vela Diagnostics Pte. Ltd. NGS-Based Monitoring and Diagnostic Test Introduction
11.17.4 Vela Diagnostics Pte. Ltd. Revenue in NGS-Based Monitoring and Diagnostic Test Business (2018-2023)
11.17.5 Vela Diagnostics Pte. Ltd. Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global NGS-Based Monitoring and Diagnostic Test Market Size Growth Rate by Type (US$ Million), 2018 VS 2023 VS 2033
Table 2. Key Players of Commercial Assays/Tests
Table 3. Key Players of Laboratory Developed Tests
Table 4. Key Players of Direct to Consumer Test
Table 5. Key Players of Pre-Commercial Tests
Table 6. Global NGS-Based Monitoring and Diagnostic Test Market Size Growth Rate by Application (US$ Million), 2018 VS 2023 VS 2033
Table 7. Global NGS-Based Monitoring and Diagnostic Test Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2023 VS 2033
Table 8. Global NGS-Based Monitoring and Diagnostic Test Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global NGS-Based Monitoring and Diagnostic Test Market Share by Region (2018-2023)
Table 10. Global NGS-Based Monitoring and Diagnostic Test Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global NGS-Based Monitoring and Diagnostic Test Market Share by Region (2024-2033)
Table 12. NGS-Based Monitoring and Diagnostic Test Market Trends
Table 13. NGS-Based Monitoring and Diagnostic Test Market Drivers
Table 14. NGS-Based Monitoring and Diagnostic Test Market Challenges
Table 15. NGS-Based Monitoring and Diagnostic Test Market Restraints
Table 16. Global NGS-Based Monitoring and Diagnostic Test Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global NGS-Based Monitoring and Diagnostic Test Revenue Share by Players (2018-2023)
Table 18. Global Top NGS-Based Monitoring and Diagnostic Test by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NGS-Based Monitoring and Diagnostic Test as of 2023)
Table 19. Global NGS-Based Monitoring and Diagnostic Test Industry Ranking 2021 VS 2023 VS 2023
Table 20. Global 5 Largest Players Market Share by NGS-Based Monitoring and Diagnostic Test Revenue (CR5 and HHI) & (2018-2023)
Table 21. Global Key Players of NGS-Based Monitoring and Diagnostic Test, Headquarters and Area Served
Table 22. Global Key Players of NGS-Based Monitoring and Diagnostic Test, Product and Application
Table 23. Global Key Players of NGS-Based Monitoring and Diagnostic Test, Product and Application
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global NGS-Based Monitoring and Diagnostic Test Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global NGS-Based Monitoring and Diagnostic Test Revenue Market Share by Type (2018-2023)
Table 27. Global NGS-Based Monitoring and Diagnostic Test Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global NGS-Based Monitoring and Diagnostic Test Revenue Market Share by Type (2024-2033)
Table 29. Global NGS-Based Monitoring and Diagnostic Test Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global NGS-Based Monitoring and Diagnostic Test Revenue Share by Application (2018-2023)
Table 31. Global NGS-Based Monitoring and Diagnostic Test Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global NGS-Based Monitoring and Diagnostic Test Revenue Share by Application (2024-2033)
Table 33. North America NGS-Based Monitoring and Diagnostic Test Market Size by Type (2018-2023) & (US$ Million)
Table 34. North America NGS-Based Monitoring and Diagnostic Test Market Size by Type (2024-2033) & (US$ Million)
Table 35. North America NGS-Based Monitoring and Diagnostic Test Market Size by Application (2018-2023) & (US$ Million)
Table 36. North America NGS-Based Monitoring and Diagnostic Test Market Size by Application (2024-2033) & (US$ Million)
Table 37. North America NGS-Based Monitoring and Diagnostic Test Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2023 VS 2033
Table 38. North America NGS-Based Monitoring and Diagnostic Test Market Size by Country (2018-2023) & (US$ Million)
Table 39. North America NGS-Based Monitoring and Diagnostic Test Market Size by Country (2024-2033) & (US$ Million)
Table 40. Europe NGS-Based Monitoring and Diagnostic Test Market Size by Type (2018-2023) & (US$ Million)
Table 41. Europe NGS-Based Monitoring and Diagnostic Test Market Size by Type (2024-2033) & (US$ Million)
Table 42. Europe NGS-Based Monitoring and Diagnostic Test Market Size by Application (2018-2023) & (US$ Million)
Table 43. Europe NGS-Based Monitoring and Diagnostic Test Market Size by Application (2024-2033) & (US$ Million)
Table 44. Europe NGS-Based Monitoring and Diagnostic Test Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2023 VS 2033
Table 45. Europe NGS-Based Monitoring and Diagnostic Test Market Size by Country (2018-2023) & (US$ Million)
Table 46. Europe NGS-Based Monitoring and Diagnostic Test Market Size by Country (2024-2033) & (US$ Million)
Table 47. China NGS-Based Monitoring and Diagnostic Test Market Size by Type (2018-2023) & (US$ Million)
Table 48. China NGS-Based Monitoring and Diagnostic Test Market Size by Type (2024-2033) & (US$ Million)
Table 49. China NGS-Based Monitoring and Diagnostic Test Market Size by Application (2018-2023) & (US$ Million)
Table 50. China NGS-Based Monitoring and Diagnostic Test Market Size by Application (2024-2033) & (US$ Million)
Table 51. Asia NGS-Based Monitoring and Diagnostic Test Market Size by Type (2018-2023) & (US$ Million)
Table 52. Asia NGS-Based Monitoring and Diagnostic Test Market Size by Type (2024-2033) & (US$ Million)
Table 53. Asia NGS-Based Monitoring and Diagnostic Test Market Size by Application (2018-2023) & (US$ Million)
Table 54. Asia NGS-Based Monitoring and Diagnostic Test Market Size by Application (2024-2033) & (US$ Million)
Table 55. Asia NGS-Based Monitoring and Diagnostic Test Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2023 VS 2033
Table 56. Asia NGS-Based Monitoring and Diagnostic Test Market Size by Region (2018-2023) & (US$ Million)
Table 57. Asia NGS-Based Monitoring and Diagnostic Test Market Size by Region (2024-2033) & (US$ Million)
Table 58. Middle East, Africa, and Latin America NGS-Based Monitoring and Diagnostic Test Market Size by Type (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America NGS-Based Monitoring and Diagnostic Test Market Size by Type (2024-2033) & (US$ Million)
Table 60. Middle East, Africa, and Latin America NGS-Based Monitoring and Diagnostic Test Market Size by Application (2018-2023) & (US$ Million)
Table 61. Middle East, Africa, and Latin America NGS-Based Monitoring and Diagnostic Test Market Size by Application (2024-2033) & (US$ Million)
Table 62. Middle East, Africa, and Latin America NGS-Based Monitoring and Diagnostic Test Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2023 VS 2033
Table 63. Middle East, Africa, and Latin America NGS-Based Monitoring and Diagnostic Test Market Size by Country (2018-2023) & (US$ Million)
Table 64. Middle East, Africa, and Latin America NGS-Based Monitoring and Diagnostic Test Market Size by Country (2024-2033) & (US$ Million)
Table 65. Agilent Technologies, Inc. Company Details
Table 66. Agilent Technologies, Inc. Business Overview
Table 67. Agilent Technologies, Inc. NGS-Based Monitoring and Diagnostic Test Product
Table 68. Agilent Technologies, Inc. Revenue in NGS-Based Monitoring and Diagnostic Test Business (2018-2023) & (US$ Million)
Table 69. Agilent Technologies, Inc. Recent Developments
Table 70. Ancestry.com LLC Company Details
Table 71. Ancestry.com LLC Business Overview
Table 72. Ancestry.com LLC NGS-Based Monitoring and Diagnostic Test Product
Table 73. Ancestry.com LLC Revenue in NGS-Based Monitoring and Diagnostic Test Business (2018-2023) & (US$ Million)
Table 74. Ancestry.com LLC Recent Developments
Table 75. ArcherDX, Inc. Company Details
Table 76. ArcherDX, Inc. Business Overview
Table 77. ArcherDX, Inc. NGS-Based Monitoring and Diagnostic Test Product
Table 78. ArcherDX, Inc. Revenue in NGS-Based Monitoring and Diagnostic Test Business (2018-2023) & (US$ Million)
Table 79. ArcherDX, Inc. Recent Developments
Table 80. Beijing Genomics Institute (BGI) Company Details
Table 81. Beijing Genomics Institute (BGI) Business Overview
Table 82. Beijing Genomics Institute (BGI) NGS-Based Monitoring and Diagnostic Test Product
Table 83. Beijing Genomics Institute (BGI) Revenue in NGS-Based Monitoring and Diagnostic Test Business (2018-2023) & (US$ Million)
Table 84. Beijing Genomics Institute (BGI) Recent Developments
Table 85. Cancer Genetics, Inc. Company Details
Table 86. Cancer Genetics, Inc. Business Overview
Table 87. Cancer Genetics, Inc. NGS-Based Monitoring and Diagnostic Test Product
Table 88. Cancer Genetics, Inc. Revenue in NGS-Based Monitoring and Diagnostic Test Business (2018-2023) & (US$ Million)
Table 89. Cancer Genetics, Inc. Recent Developments
Table 90. CENTOGENE AG Company Details
Table 91. CENTOGENE AG Business Overview
Table 92. CENTOGENE AG NGS-Based Monitoring and Diagnostic Test Product
Table 93. CENTOGENE AG Revenue in NGS-Based Monitoring and Diagnostic Test Business (2018-2023) & (US$ Million)
Table 94. CENTOGENE AG Recent Developments
Table 95. F. Hoffmann-La Roche Ltd Company Details
Table 96. F. Hoffmann-La Roche Ltd Business Overview
Table 97. F. Hoffmann-La Roche Ltd NGS-Based Monitoring and Diagnostic Test Product
Table 98. F. Hoffmann-La Roche Ltd Revenue in NGS-Based Monitoring and Diagnostic Test Business (2018-2023) & (US$ Million)
Table 99. F. Hoffmann-La Roche Ltd Recent Developments
Table 100. GenePath Dx Company Details
Table 101. GenePath Dx Business Overview
Table 102. GenePath Dx NGS-Based Monitoring and Diagnostic Test Product
Table 103. GenePath Dx Revenue in NGS-Based Monitoring and Diagnostic Test Business (2018-2023) & (US$ Million)
Table 104. GenePath Dx Recent Developments
Table 105. Illumina, Inc. Company Details
Table 106. Illumina, Inc. Business Overview
Table 107. Illumina, Inc. NGS-Based Monitoring and Diagnostic Test Product
Table 108. Illumina, Inc. Revenue in NGS-Based Monitoring and Diagnostic Test Business (2018-2023) & (US$ Million)
Table 109. Illumina, Inc. Recent Developments
Table 110. Laboratory Corporation of America Holdings Company Details
Table 111. Laboratory Corporation of America Holdings Business Overview
Table 112. Laboratory Corporation of America Holdings NGS-Based Monitoring and Diagnostic Test Product
Table 113. Laboratory Corporation of America Holdings Revenue in NGS-Based Monitoring and Diagnostic Test Business (2018-2023) & (US$ Million)
Table 114. Laboratory Corporation of America Holdings Recent Developments
Table 115. Myriad Genetics, Inc. Company Details
Table 116. Myriad Genetics, Inc. Business Overview
Table 117. Myriad Genetics, Inc. NGS-Based Monitoring and Diagnostic Test Product
Table 118. Myriad Genetics, Inc. Revenue in NGS-Based Monitoring and Diagnostic Test Business (2018-2023) & (US$ Million)
Table 119. Myriad Genetics, Inc. Recent Developments
Table 120. QIAGEN N.V. Company Details
Table 121. QIAGEN N.V. Business Overview
Table 122. QIAGEN N.V. NGS-Based Monitoring and Diagnostic Test Product
Table 123. QIAGEN N.V. Revenue in NGS-Based Monitoring and Diagnostic Test Business (2018-2023) & (US$ Million)
Table 124. QIAGEN N.V. Recent Developments
Table 125. Quest Diagnostics Incorporated Company Details
Table 126. Quest Diagnostics Incorporated Business Overview
Table 127. Quest Diagnostics Incorporated NGS-Based Monitoring and Diagnostic Test Product
Table 128. Quest Diagnostics Incorporated Revenue in NGS-Based Monitoring and Diagnostic Test Business (2018-2023) & (US$ Million)
Table 129. Quest Diagnostics Incorporated Recent Developments
Table 130. Siemens Healthineers, Inc. Company Details
Table 131. Siemens Healthineers, Inc. Business Overview
Table 132. Siemens Healthineers, Inc. NGS-Based Monitoring and Diagnostic Test Product
Table 133. Siemens Healthineers, Inc. Revenue in NGS-Based Monitoring and Diagnostic Test Business (2018-2023) & (US$ Million)
Table 134. Siemens Healthineers, Inc. Recent Developments
Table 135. Thermo Fisher Scientific Inc. Company Details
Table 136. Thermo Fisher Scientific Inc. Business Overview
Table 137. Thermo Fisher Scientific Inc. NGS-Based Monitoring and Diagnostic Test Product
Table 138. Thermo Fisher Scientific Inc. Revenue in NGS-Based Monitoring and Diagnostic Test Business (2018-2023) & (US$ Million)
Table 139. Thermo Fisher Scientific Inc. Recent Developments
Table 140. HTG Molecular Diagnostics, Inc. Company Details
Table 141. HTG Molecular Diagnostics, Inc. Business Overview
Table 142. HTG Molecular Diagnostics, Inc. NGS-Based Monitoring and Diagnostic Test Product
Table 143. HTG Molecular Diagnostics, Inc. Revenue in NGS-Based Monitoring and Diagnostic Test Business (2018-2023) & (US$ Million)
Table 144. HTG Molecular Diagnostics, Inc. Recent Developments
Table 145. Vela Diagnostics Pte. Ltd. Company Details
Table 146. Vela Diagnostics Pte. Ltd. Business Overview
Table 147. Vela Diagnostics Pte. Ltd. NGS-Based Monitoring and Diagnostic Test Product
Table 148. Vela Diagnostics Pte. Ltd. Revenue in NGS-Based Monitoring and Diagnostic Test Business (2018-2023) & (US$ Million)
Table 149. Vela Diagnostics Pte. Ltd. Recent Developments
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
List of Figures
Figure 1. Global NGS-Based Monitoring and Diagnostic Test Market Size Growth Rate by Type, 2018 VS 2023 VS 2033 (US$ Million)
Figure 2. Global NGS-Based Monitoring and Diagnostic Test Market Share by Type: 2023 VS 2033
Figure 3. Commercial Assays/Tests Features
Figure 4. Laboratory Developed Tests Features
Figure 5. Direct to Consumer Test Features
Figure 6. Pre-Commercial Tests Features
Figure 7. Global NGS-Based Monitoring and Diagnostic Test Market Size Growth Rate by Application, 2018 VS 2023 VS 2033 (US$ Million)
Figure 8. Global NGS-Based Monitoring and Diagnostic Test Market Share by Application: 2023 VS 2033
Figure 9. Out-Patient Clinics/General Practitioners Case Studies
Figure 10. Diagnostic Centers Case Studies
Figure 11. Hospitals Case Studies
Figure 12. Others Case Studies
Figure 13. NGS-Based Monitoring and Diagnostic Test Report Years Considered
Figure 14. Global NGS-Based Monitoring and Diagnostic Test Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 15. Global NGS-Based Monitoring and Diagnostic Test Market Size, (US$ Million), 2018 VS 2023 VS 2033
Figure 16. Global NGS-Based Monitoring and Diagnostic Test Market Share by Region: 2023 VS 2033
Figure 17. Global NGS-Based Monitoring and Diagnostic Test Market Share by Players in 2023
Figure 18. Global Top NGS-Based Monitoring and Diagnostic Test Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NGS-Based Monitoring and Diagnostic Test as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by NGS-Based Monitoring and Diagnostic Test Revenue in 2023
Figure 20. North America NGS-Based Monitoring and Diagnostic Test Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. North America NGS-Based Monitoring and Diagnostic Test Market Share by Type (2018-2033)
Figure 22. North America NGS-Based Monitoring and Diagnostic Test Market Share by Application (2018-2033)
Figure 23. North America NGS-Based Monitoring and Diagnostic Test Market Share by Country (2018-2033)
Figure 24. United States NGS-Based Monitoring and Diagnostic Test Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Canada NGS-Based Monitoring and Diagnostic Test Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Europe NGS-Based Monitoring and Diagnostic Test Market Size YoY (2018-2033) & (US$ Million)
Figure 27. Europe NGS-Based Monitoring and Diagnostic Test Market Share by Type (2018-2033)
Figure 28. Europe NGS-Based Monitoring and Diagnostic Test Market Share by Application (2018-2033)
Figure 29. Europe NGS-Based Monitoring and Diagnostic Test Market Share by Country (2018-2033)
Figure 30. Germany NGS-Based Monitoring and Diagnostic Test Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. France NGS-Based Monitoring and Diagnostic Test Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. U.K. NGS-Based Monitoring and Diagnostic Test Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Italy NGS-Based Monitoring and Diagnostic Test Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Russia NGS-Based Monitoring and Diagnostic Test Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Nordic Countries NGS-Based Monitoring and Diagnostic Test Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. China NGS-Based Monitoring and Diagnostic Test Market Size YoY (2018-2033) & (US$ Million)
Figure 37. China NGS-Based Monitoring and Diagnostic Test Market Share by Type (2018-2033)
Figure 38. China NGS-Based Monitoring and Diagnostic Test Market Share by Application (2018-2033)
Figure 39. Asia NGS-Based Monitoring and Diagnostic Test Market Size YoY (2018-2033) & (US$ Million)
Figure 40. Asia NGS-Based Monitoring and Diagnostic Test Market Share by Type (2018-2033)
Figure 41. Asia NGS-Based Monitoring and Diagnostic Test Market Share by Application (2018-2033)
Figure 42. Asia NGS-Based Monitoring and Diagnostic Test Market Share by Region (2018-2033)
Figure 43. Japan NGS-Based Monitoring and Diagnostic Test Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. South Korea NGS-Based Monitoring and Diagnostic Test Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. China Taiwan NGS-Based Monitoring and Diagnostic Test Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Southeast Asia NGS-Based Monitoring and Diagnostic Test Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. India NGS-Based Monitoring and Diagnostic Test Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Australia NGS-Based Monitoring and Diagnostic Test Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America NGS-Based Monitoring and Diagnostic Test Market Size YoY (2018-2033) & (US$ Million)
Figure 50. Middle East, Africa, and Latin America NGS-Based Monitoring and Diagnostic Test Market Share by Type (2018-2033)
Figure 51. Middle East, Africa, and Latin America NGS-Based Monitoring and Diagnostic Test Market Share by Application (2018-2033)
Figure 52. Middle East, Africa, and Latin America NGS-Based Monitoring and Diagnostic Test Market Share by Country (2018-2033)
Figure 53. Brazil NGS-Based Monitoring and Diagnostic Test Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Mexico NGS-Based Monitoring and Diagnostic Test Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. Turkey NGS-Based Monitoring and Diagnostic Test Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. Saudi Arabia NGS-Based Monitoring and Diagnostic Test Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. Israel NGS-Based Monitoring and Diagnostic Test Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 58. GCC Countries NGS-Based Monitoring and Diagnostic Test Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 59. Agilent Technologies, Inc. Revenue Growth Rate in NGS-Based Monitoring and Diagnostic Test Business (2018-2023)
Figure 60. Ancestry.com LLC Revenue Growth Rate in NGS-Based Monitoring and Diagnostic Test Business (2018-2023)
Figure 61. ArcherDX, Inc. Revenue Growth Rate in NGS-Based Monitoring and Diagnostic Test Business (2018-2023)
Figure 62. Beijing Genomics Institute (BGI) Revenue Growth Rate in NGS-Based Monitoring and Diagnostic Test Business (2018-2023)
Figure 63. Cancer Genetics, Inc. Revenue Growth Rate in NGS-Based Monitoring and Diagnostic Test Business (2018-2023)
Figure 64. CENTOGENE AG Revenue Growth Rate in NGS-Based Monitoring and Diagnostic Test Business (2018-2023)
Figure 65. F. Hoffmann-La Roche Ltd Revenue Growth Rate in NGS-Based Monitoring and Diagnostic Test Business (2018-2023)
Figure 66. GenePath Dx Revenue Growth Rate in NGS-Based Monitoring and Diagnostic Test Business (2018-2023)
Figure 67. Illumina, Inc. Revenue Growth Rate in NGS-Based Monitoring and Diagnostic Test Business (2018-2023)
Figure 68. Laboratory Corporation of America Holdings Revenue Growth Rate in NGS-Based Monitoring and Diagnostic Test Business (2018-2023)
Figure 69. Myriad Genetics, Inc. Revenue Growth Rate in NGS-Based Monitoring and Diagnostic Test Business (2018-2023)
Figure 70. QIAGEN N.V. Revenue Growth Rate in NGS-Based Monitoring and Diagnostic Test Business (2018-2023)
Figure 71. Quest Diagnostics Incorporated Revenue Growth Rate in NGS-Based Monitoring and Diagnostic Test Business (2018-2023)
Figure 72. Siemens Healthineers, Inc. Revenue Growth Rate in NGS-Based Monitoring and Diagnostic Test Business (2018-2023)
Figure 73. Thermo Fisher Scientific Inc. Revenue Growth Rate in NGS-Based Monitoring and Diagnostic Test Business (2018-2023)
Figure 74. HTG Molecular Diagnostics, Inc. Revenue Growth Rate in NGS-Based Monitoring and Diagnostic Test Business (2018-2023)
Figure 75. Vela Diagnostics Pte. Ltd. Revenue Growth Rate in NGS-Based Monitoring and Diagnostic Test Business (2018-2023)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed